<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00952562</url>
  </required_header>
  <id_info>
    <org_study_id>7. juli 2009, version 1</org_study_id>
    <nct_id>NCT00952562</nct_id>
  </id_info>
  <brief_title>The Influence of Vitamin D on Mineral Metabolism, Blood Pressure and Pulse Wave Analysis in Healthy Individuals</brief_title>
  <official_title>The Influence of Vitamin D on Mineral Metabolism, Blood Pressure and Pulse Wave Analysis in Healthy Individuals. A Randomised Double Blinded Placebo Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zealand University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized placebo controlled trial evaluating the effect of the recently recommended high
      doses of cholecalciferol (3000 IU/day) on mineral metabolism, blood pressure and pulse wave
      analysis in healthy individuals.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>urinary calcium excretion</measure>
    <time_frame>before and after 16 weeks of intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>25 hydroxyvitamin D</measure>
    <time_frame>before and after 16 weeks og treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1,25 dihydroxyvitamin D</measure>
    <time_frame>before and after 16 weeks of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urinary creatinin</measure>
    <time_frame>before and after 16 weeks of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urinary protein</measure>
    <time_frame>before and after 16 weeks of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urinary phosphorous</measure>
    <time_frame>before and after 16 weeks of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>p-FGF23</measure>
    <time_frame>before and after 16 weeks of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
    <time_frame>before and after 16 weeks of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pulse wave velocity</measure>
    <time_frame>before and after 16 weeks of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>augmentation index</measure>
    <time_frame>before and after 16 weeks of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>central blood pressure</measure>
    <time_frame>before and after 16 weeks of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>p-phosphate</measure>
    <time_frame>before and after 16 weeks of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ionised p-calcium</measure>
    <time_frame>before and after 16 weeks of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>p-iPTH</measure>
    <time_frame>before and after 16 weeks of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>alkalic phosphatase</measure>
    <time_frame>before and after 16 weeks of treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>cholecalciferol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3000 IU cholecalciferol per day for 16 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>cholecalciferol</intervention_name>
    <description>Capsule cholecalciferol 1000 IU, 3 capsules per day for 16 weeks</description>
    <arm_group_label>cholecalciferol</arm_group_label>
    <other_name>D3-Vitamin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Empty capsules, 3 capsules per day for 16 weeks</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt; 18 years old

          -  p 25OH vitaminD&lt;50nmol/l

          -  signed informed consent

        Exclusion Criteria:

          -  receiving antihypertensive or antidiabetic treatment

          -  sarcoidoses

          -  history of kidney stones

          -  receiving 1-alfa-hydroxylated vitamin D treatment

          -  plasma creatinin &gt; 120 micromol/l

          -  ionised calcium &gt; 1,5 mmol/l

          -  treatment with calcimimetics

          -  active malignancy

          -  intestinal malabsorption

          -  active pancreatitis

          -  former hospitalisation due to alcoholic related disease

          -  using euphoriant drugs

          -  pregnancy or risk of being pregnant or lactating women

          -  Known allergy to cholecalciferol capsules
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ditte Hansen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zealand University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Niels Erik Frandsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zealand University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Knud Rasmussen, DmSci</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zealand University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lisbet Brandi, DmSci</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zealand University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hans Christian Hoeck, DmSci</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center for clinical and basic research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Roskilde Hospital</name>
      <address>
        <city>Roskilde</city>
        <zip>4000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2009</study_first_submitted>
  <study_first_submitted_qc>August 4, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2009</study_first_posted>
  <last_update_submitted>August 23, 2011</last_update_submitted>
  <last_update_submitted_qc>August 23, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 24, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vitamin d</keyword>
  <keyword>calcium</keyword>
  <keyword>blood pressure</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

